GLP Collection

GLP-2 TZ & Eloralintide

Name: GLP-2 TZ & Eloralintide
Brand: Disguised Alpha
SKU: GLP2TZ-Elora
Price: 159.99 USD
Availability: OutOfStock

Lyophilized in the USA4813.45 g/molDual GIP/GLP-1 receptor agonist

GLP-2 TZ / Eloralintide is a two-compound lyophilized research blend labeled 20 mg tirzepatide plus 5 mg eloralintide per vial. The combined labeled amount is 25 mg. GLP-2 TZ is the catalog name used for tirzepatide.

Out of stockEarn 159 points

Quantity

$159.99

Save 10% with code WELCOME10 at checkout

Bundle & save

COA

Referral program · researchers save 10%, you earn 15% back

FedEx 2-Day shipping

Free on orders over $250

Ships from Irvine, California

Tracked delivery on every order

Per-batch COA access

Every order ships with certificate access for its lot

Secure encrypted checkout CASH APP 5% OFFZELLE 5% OFFBANK TRANSFER 5% OFFCHIME 5% OFFCRYPTO 7% OFFVISA · AMEX NO FEE

Commonly Researched With

The compounds researchers order most, by verified order volume.

Best Seller

Bacteriostatic Water 0.9%From $12.99 Best Seller

GLP-3 RTFrom $49.99 Best Seller

GHK-CuFrom $44.99 Best Seller

TesamorelinFrom $79.99

More ways to save

Up to20%OFF

Bulk Orders 20+ vials

Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.

Ask about bulk

Technical specifications

Compound Information

Peptide storage guide How to reconstitute peptides

Molecular Profile

What is GLP-2 TZ & Eloralintide?

Molecular FormulaC₂₂₅H₃₄₈N₄₈O₆₈

Molecular Weight4813.45g/mol

Peptide ClassDual GIP/GLP-1 receptor agonist

Storage Requirements

Stability information.

Avoid freeze/thaw cyclesProtect from lightRefrigerate after reconstitution

−20°C

Lyophilized powder, as shipped

The most stable form. Store cold and protected from light until it is reconstituted.

2–8°C

After reconstitution

Refrigerate once reconstituted and keep it protected from light.

Important research notice

Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.

All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.

By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.

GLP-2 TZ & Eloralintide: product details and research reference

Tirzepatide and eloralintide blend: 20 mg / 5 mg

Product specifications

Tirzepatide labeled content

20 mg per vial

Eloralintide labeled content

5 mg per vial

Combined labeled content

25 mg

Labeled mass ratio

4:1

Format

Lyophilized two-compound research vial

What are the two compounds?

Tirzepatide is associated with GIP and GLP-1 receptor agonism. Eloralintide, also called LY3841136, is an investigational selective amylin receptor agonist. The blend therefore brings together compounds associated with three receptor pathways, while remaining a two-compound formulation.

Does GLP-2 TZ mean a GLP-2 receptor agonist?

No. GLP-2 TZ is a catalog designation. Tirzepatide is scientifically described as a dual GIP/GLP-1 receptor agonist. It should not be confused with the endogenous GLP-2 peptide or a GLP-2 receptor agonist.

Is the blend the same as eloralintide alone?

No. Eloralintide 10 mg is a separate single-compound listing. This blend has 5 mg eloralintide together with 20 mg tirzepatide. The components and their individual labeled quantities differ.

Does the 4:1 ratio establish clinical equivalence?

No. It describes the labeled masses only. Sponsor studies use their own formulations and protocols. Those findings do not validate the stability, safety, efficacy or pharmacokinetics of this particular finished research blend.

Research sources and related reading

Selected research and evidence

Primary research relevant to the named compound or clearly identified component is linked below. Experimental results depend on identity, model and formulation.

LY3298176: dual GIP/GLP-1 receptor characterizationDiscovery, preclinical and phase 1 research · 2018 · PMID 30473097
Characterized tirzepatide in receptor assays, animal models and an investigational clinical formulation. These results do not establish equivalence of this listing to a sponsor product.
Eloralintide / LY3841136 discovery and translationPreclinical and translational research · 2025 · PMID 41109426
Examined the amylin receptor agonist as an investigational compound. Eloralintide and cagrilintide are distinct molecules.

Documentation and research handling

Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.

Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.

Product questions

What does the vial quantity describe?

The listed milligrams refer to material per vial, not concentration or administration instructions. A prepared solution has its own concentration and stability requirements. Verify the exact selected option and shipping lot.

Where is the batch-specific evidence?

Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.

Do these studies test this finished product?

The references describe the materials and conditions used by their authors. They do not establish that this commercial formulation was tested. For blends, evidence on an individual component does not validate the finished mixture or establish synergy.